220 related articles for article (PubMed ID: 22300739)
1. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.
Burnett-Bowie SA; Leder BZ; Henao MP; Baldwin CM; Hayden DL; Finkelstein JS
Clin J Am Soc Nephrol; 2012 Apr; 7(4):624-31. PubMed ID: 22300739
[TBL] [Abstract][Full Text] [Related]
2. Effects of Vitamin D
Batacchi Z; Robinson-Cohen C; Hoofnagle AN; Isakova T; Kestenbaum B; Martin KJ; Wolf MS; de Boer IH
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1498-1506. PubMed ID: 28768705
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
4. Nutritional vitamin D supplementation in dialysis: a randomized trial.
Bhan I; Dobens D; Tamez H; Deferio JJ; Li YC; Warren HS; Ankers E; Wenger J; Tucker JK; Trottier C; Pathan F; Kalim S; Nigwekar SU; Thadhani R
Clin J Am Soc Nephrol; 2015 Apr; 10(4):611-9. PubMed ID: 25770176
[TBL] [Abstract][Full Text] [Related]
5. Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?
Qunibi WY; Abdellatif A; Sankar S; Hamdan Z; Lin FY; Ingle J; Cadena A; Gelfond J; Kasinath B
Clin Nephrol; 2010 Apr; 73(4):276-85. PubMed ID: 20353735
[TBL] [Abstract][Full Text] [Related]
6. Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis.
de Jong MA; Petrykiv SI; Laverman GD; van Herwaarden AE; de Zeeuw D; Bakker SJL; Heerspink HJL; de Borst MH
Clin J Am Soc Nephrol; 2019 Jan; 14(1):66-73. PubMed ID: 30559106
[TBL] [Abstract][Full Text] [Related]
7. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.
Shroff R; Wan M; Gullett A; Ledermann S; Shute R; Knott C; Wells D; Aitkenhead H; Manickavasagar B; van't Hoff W; Rees L
Clin J Am Soc Nephrol; 2012 Feb; 7(2):216-23. PubMed ID: 22266572
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.
Al-Aly Z; Qazi RA; González EA; Zeringue A; Martin KJ
Am J Kidney Dis; 2007 Jul; 50(1):59-68. PubMed ID: 17591525
[TBL] [Abstract][Full Text] [Related]
9. Treatment Effect of Ergocalciferol on Bone Metabolism Indexes and Parathyroid Hormone in Hemodialysis Patients.
Bashardoust B; Zakeri A; Fouladi N; Izadi Z; Hosseini F
Iran J Kidney Dis; 2018 Nov; 12(6):359-363. PubMed ID: 30595565
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Potassium-Binding Polymer Patiromer on Markers of Mineral Metabolism.
Bushinsky DA; Spiegel DM; Yuan J; Warren S; Fogli J; Pergola PE
Clin J Am Soc Nephrol; 2019 Jan; 14(1):103-110. PubMed ID: 30381412
[TBL] [Abstract][Full Text] [Related]
11. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
[TBL] [Abstract][Full Text] [Related]
12. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
Ramirez-Sandoval JC; Arvizu-Hernandez M; Cruz C; Vazquez-Cantu B; Rojas-Concha LJ; Tamez L; Reynerio F; Gomez FE; Correa-Rotter R
J Nephrol; 2019 Aug; 32(4):645-659. PubMed ID: 30888584
[TBL] [Abstract][Full Text] [Related]
13. Oral vitamin D
Charoenngam N; Rujirachun P; Holick MF; Ungprasert P
Osteoporos Int; 2019 Nov; 30(11):2183-2193. PubMed ID: 31372708
[TBL] [Abstract][Full Text] [Related]
14. Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients.
Rousseau AF; Damas P; Ledoux D; Cavalier E
Burns; 2014 Aug; 40(5):865-70. PubMed ID: 24462294
[TBL] [Abstract][Full Text] [Related]
15. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
Fisk CM; Theobald HE; Sanders TA
J Nutr; 2012 Jul; 142(7):1286-90. PubMed ID: 22623396
[TBL] [Abstract][Full Text] [Related]
16. Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial.
Mitchell DM; Leder BZ; Cagliero E; Mendoza N; Henao MP; Hayden DL; Finkelstein JS; Burnett-Bowie SA
Am J Clin Nutr; 2015 Aug; 102(2):385-92. PubMed ID: 26156733
[TBL] [Abstract][Full Text] [Related]
17. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.
Vervloet MG; van Ittersum FJ; Büttler RM; Heijboer AC; Blankenstein MA; ter Wee PM
Clin J Am Soc Nephrol; 2011 Feb; 6(2):383-9. PubMed ID: 21030580
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women.
Mueangpaisarn P; Chaiamnuay S
Aging Clin Exp Res; 2020 Jan; 32(1):41-48. PubMed ID: 30784012
[TBL] [Abstract][Full Text] [Related]
19. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.
Dickerson RN; Berry SC; Ziebarth JD; Swanson JM; Maish GO; Minard G; Brown RO
Nutrition; 2015 Oct; 31(10):1219-23. PubMed ID: 26213135
[TBL] [Abstract][Full Text] [Related]
20. Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.
Mazzaferro S; Pasquali M; Pugliese F; Citterio F; Gargiulo A; Rotondi S; Tartaglione L; Conte C; Pirrò G; Taggi F
J Nephrol; 2012; 25(6):1108-18. PubMed ID: 22383345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
